Leadership Overview
Biotronik has 4 executives leading key functions including finance, medical affairs, neuromodulation, and overall operations.
Driven by a commitment to innovation, Biotronik provides comprehensive solutions for diagnosis, treatment, and therapy support across cardiac rhythm management, electrophysiology, and vascular intervention, impacting global healthcare.
Driven by a commitment to innovation, Biotronik provides comprehensive solutions for diagnosis, treatment, and therapy support across cardiac rhythm management, electrophysiology, and vascular intervention, impacting global healthcare.
Leadership Roles at Biotronik
James Felsted - Vice President, Finance & Chief Financial Officer, Administration, Region (US)
James Felsted, the Vice President, Finance & Chief Financial Officer, Administration, Region (US) at Biotronik, directs financial strategy and administration for the United States region. Overseeing all fiscal operations, Felsted ensures robust financial planning, accurate reporting, and efficient resource allocation to support Biotronik's market objectives. This leadership position involves managing budgets, optimizing financial performance, and driving fiscal discipline across the organization. By implementing sound financial controls and strategic investments, James Felsted strengthens the company's economic foundation and supports its growth initiatives in the critical US market. The scope of this role encompasses treasury functions, accounting oversight, and financial analysis to inform executive decision-making and maintain market competitiveness.
Todd Langevin - President Neuromodulation
Todd Langevin, the President Neuromodulation at Biotronik, spearheads the strategic direction and operational execution for the neuromodulation division. Langevin drives innovation and market expansion within this specialized segment, focusing on developing and delivering advanced therapies. This leadership role involves overseeing product lifecycles, from research and development through market introduction and ongoing support. By fostering cross-functional collaboration, Todd Langevin ensures that the neuromodulation business unit achieves its growth targets and enhances patient outcomes. The President Neuromodulation's mandate includes building strong relationships with healthcare providers and key opinion leaders to advance the adoption of Biotronik's cutting-edge neuromodulation technologies, solidifying the company's presence in this vital area of medical intervention.
Ryan Walters - President
Ryan Walters, the President at Biotronik, directs the overall strategic vision and operational management of the company. Walters is responsible for driving business growth, enhancing market presence, and ensuring the successful execution of corporate objectives across all divisions. This executive position involves leading cross-functional teams to deliver comprehensive solutions in cardiac rhythm management, electrophysiology, and vascular intervention. By fostering a culture of innovation and operational excellence, Ryan Walters guides Biotronik's commitment to improving patient lives through advanced medical technologies. The President's oversight extends to global market strategies, resource allocation, and maintaining strong stakeholder relationships, ensuring Biotronik's continued leadership and impact in the healthcare industry.
David Hayes - Chief Medical Officer
David Hayes, the Chief Medical Officer at Biotronik, guides the company's medical strategy and clinical development initiatives. Hayes oversees the integration of clinical insights into product development and ensures adherence to the highest medical standards across all therapeutic areas. This critical role involves collaborating with research and development teams to advance innovative solutions in cardiac rhythm management, electrophysiology, and vascular intervention. By providing expert medical direction, David Hayes champions the clinical efficacy and patient benefit of Biotronik's technologies. The Chief Medical Officer's responsibilities extend to engaging with the global medical community, fostering key relationships, and ensuring that Biotronik's offerings align with evolving healthcare needs and regulatory requirements, thereby reinforcing the company's position as a leader in medical technology.
Explore Leadership Teams in Manufacturing
Hologic is a global medical technology leader focused on improving womens health and wellbeing through early detection, diagnosis, and treatment solutions. The company develops and supplies advanced diagnostic products, imaging systems, and surgical tools that support clinical care across breast health, gynecological care and infectious disease testing. With a strong innovation culture and worldwide presence, Hologic partners with healthcare professionals to raise standards of care and help patients live healthier lives.
Company Leadership
Advita Ortho, headquartered in Gainesville, Florida, is a global medical device company dedicated to advancing patient lives through innovative orthopedic solutions. Officially launched in November 2025, the company delivers high-quality orthopedic implants and a comprehensive suite of integrated surgical technologies powered by data, artificial intelligence, and machine learning. Advita Ortho owns and distributes established product lines including the Equinoxe Shoulder, Vantage Ankle, Alteon Hip, Truliant Knee, Newton balancing technology, and GPS navigation systems, among others. The company's portfolio creates an ecosystem designed to enhance surgical decision-making in the operating room while driving efficiency for healthcare systems. Led by industry veterans and backed by investment firms including Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management, Advita Ortho positions itself as a trusted partner to orthopedic surgeons worldwide, providing tools and technologies designed to improve patient outcomes and quality of life.
Company Leadership
CooperVision is committed to helping people around the world see better every day. Through scientific and technological innovation, operational excellence and close working relationships with our eye care professional customers, CooperVision has helped improve the vision of millions and become a trusted global leader in the contact lens industry. CooperVision designs and manufactures innovative, high quality contact lenses to meet a remarkably wide range of wearer needs. We conduct extensive ongoing research and development in optical science. And we collaborate closely with eye care professionals, who help us identify the evolving needs of contact lens wearers around the world.
Company Leadership SR
CH
ZEISS is an international technology enterprise operating in the fields of optics and optoelectronics. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and semiconductor manufacturing equipment. The company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).
Company Leadership MM
CN
BS
Frequently Asked Questions Regarding Biotronik Top Executives and Leadership Team
